Protein Information

ID 3088
Name 6 pts
Synonyms 6 PTS; 6 pyruvoyl tetrahydrobiopterin synthase; 6 pyruvoyltetrahydropterin synthase; PTP synthase; PTPS; PTS; 6 pyruvoyl tetrahydrobiopterin synthases; 6 pyruvoyltetrahydropterin synthases…

Compound Information

ID 1468
Name HCH
CAS 1,2,3,4,5,6-hexachlorocyclohexane

Reference

PubMed Abstract RScore(About this table)
9340575 Paragh G, Varga Z, Szabolcs M, Kovacs E, Balogh Z, Foris G: [Abnormal function of lipoprotein receptors in the monocytes of hypercholesteremic patients]. Orv Hetil. 1997 Sep 7;138(36 Suppl 2):2298-301.
The familial hypercholesterinemia (HCh) is as a genetically determined disorder. The genetical damage and functional abnormalities of the LDL receptors lead to familial Hch. The LDL plays an important role in cholesterol metabolism. They carry cholesterol which metabolizes through specific and scavenger LDL receptors. The ApoB100 particle of LDL binds to the receptors, internalizated, and digested, and the remaining free cholesterol regulates the intracellular cholesterol synthesis. It inhibits the key enzyme, HMG-CoA reductase and decreases the LDL receptor synthesis and increases cholesterol esterification. These mechanism can prevent the cholesterol accumulation of the cells. The aim of the present study was to clarify the activity and number of the LDL receptor, to study the LDL binding and degradation and to evaluate how the intracellular cholesterol can regulate the synthesis in patients with HCh. 58 pts with HCh and their monocytes were investigated, because the monocyte derived macrophages contained both specific and scavenger receptors. Monocytes of the pts were compared to the healthy individual controls. From the results it could be recognized--that the decreased binding to the specific LDL receptors only at 6 pts cholesterol synthesis was elevated in HCh pts group, while the synthesis inhibition induced by 50 micrograms LDL was decreased. The presented experimental results suggested that the decreased binding ability to LDL receptors is a rare cause of cholesterol abnormalities, while during the intracellular degradation process more metabolic steps can be damaged in patients with HCh.
81(1,1,1,1)